# Safety and Tolerability of Yaq-001 in Patients With Non-Alcoholic Steatohepatitis

> **NCT03962608** · NA · WITHDRAWN · sponsor: **Yaqrit Ltd**

## Conditions studied

- Non-Alcoholic Steatohepatitis

## Interventions

- **DEVICE:** Yaq-001
- **DEVICE:** Placebo

## Key facts

- **NCT ID:** NCT03962608
- **Lead sponsor:** Yaqrit Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-01-31
- **Primary completion:** 2021-01-31
- **Final completion:** 2021-01-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study was not approved by Health Authorities until get the results of the previous study
- **Last updated:** 2022-03-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03962608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03962608, "Safety and Tolerability of Yaq-001 in Patients With Non-Alcoholic Steatohepatitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03962608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*